Revolution Medicines, Inc. (RVMD)
203.77
+0.42
(+0.21%)
USD |
NASDAQ |
Sep 11, 16:00
203.85
+0.08
(+0.04%)
After-Hours: 20:00
Revolution Medicines Price to Book Value : 16.75 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 16.75 |
| September 10, 2026 | 16.72 |
| September 09, 2026 | 17.07 |
| September 08, 2026 | 17.04 |
| September 04, 2026 | 17.26 |
| September 03, 2026 | 17.33 |
| September 02, 2026 | 17.20 |
| September 01, 2026 | 17.25 |
| August 31, 2026 | 16.90 |
| August 28, 2026 | 17.09 |
| August 27, 2026 | 18.18 |
| August 26, 2026 | 17.71 |
| August 25, 2026 | 17.38 |
| August 24, 2026 | 17.39 |
| August 21, 2026 | 17.22 |
| August 20, 2026 | 17.41 |
| August 19, 2026 | 17.65 |
| August 18, 2026 | 17.76 |
| August 17, 2026 | 17.43 |
| August 14, 2026 | 16.75 |
| August 13, 2026 | 16.61 |
| August 12, 2026 | 16.87 |
| August 11, 2026 | 16.90 |
| August 10, 2026 | 17.01 |
| August 07, 2026 | 16.86 |
| Date | Value |
|---|---|
| August 06, 2026 | 16.26 |
| August 05, 2026 | 16.22 |
| August 04, 2026 | 15.90 |
| August 03, 2026 | 15.00 |
| July 31, 2026 | 15.42 |
| July 30, 2026 | 15.80 |
| July 29, 2026 | 14.87 |
| July 28, 2026 | 15.11 |
| July 27, 2026 | 15.46 |
| July 24, 2026 | 15.56 |
| July 23, 2026 | 15.52 |
| July 22, 2026 | 15.05 |
| July 21, 2026 | 15.07 |
| July 20, 2026 | 14.83 |
| July 17, 2026 | 15.30 |
| July 16, 2026 | 14.73 |
| July 15, 2026 | 15.16 |
| July 14, 2026 | 15.21 |
| July 13, 2026 | 15.12 |
| July 10, 2026 | 15.36 |
| July 09, 2026 | 15.71 |
| July 08, 2026 | 15.60 |
| July 07, 2026 | 15.66 |
| July 06, 2026 | 15.62 |
| July 02, 2026 | 15.56 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Erasca, Inc. | 13.72 |
| Moderna, Inc. | 8.496 |
| Tango Therapeutics, Inc. | 3.908 |
| Arrowhead Pharmaceuticals, Inc. | 25.12 |
| Intellia Therapeutics, Inc. | 2.259 |
Price to Book Value Related Metrics
| PEG Ratio | -0.2416 |
| Price | 203.77 |
| Earnings Yield | -4.33% |
| Market Cap | 43.66B |
| PEGY Ratio | -0.2416 |